Atai Life Sciences N.V. financials at a glance
| Year | Year | 2021 | 2022 | 2020 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$20.38M | $0.23M | $0.00M | $0.31M | $0.00M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 0.00% | 100.00% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EPS | Earnings Per Share |
|
$-1.21 | $-0.98 | $-0.25 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
-0.00% | -0.00% | 0 | 0 | 0 |
| Sha. | Shares |
|
160.3m | 160.71m | 0m | 166.01m | 167.41m |
| OCF | Operating Cash Flow |
|
$-63.25M | $-104.47M | $-20.77M | $-84.12M | $0.00M |
| FCF | Free Cash Flow |
|
$-63.42M | $-105.24M | $-20.83M | $-85.60M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.47 | $-0.68 | $-2.24 | $-0.53 | $0.00 |